Tuberculosis Disease in Children and Adolescents on Therapy With Antitumor Necrosis Factor-ɑ Agents: A Collaborative, Multicenter Paediatric Tuberculosis Network European Trials Group (ptbnet) Study
Antoni Noguera‐Julián(Hospital Sant Joan de Déu Barcelona), Marc Tebruegge(The University of Melbourne), Carmelo Guerrero-Laleona(Universidad de Zaragoza), Iveta Ozere(Riga East University Hospital), Marija Jelušić(Unknown), Fiona Shackley(National Health Service), Florian Göetzinger(Wilhelminen Hospital), Isabel Carvalho(Centro Hospitalar de Vila Nova de Gaia), Tim Niehues(Helios Klinikum Krefeld), Nicole Ritz(The University of Melbourne), Steven Welch(University Hospitals Birmingham NHS Foundation Trust), Michael Buettcher(University of Lucerne), Robindra Basu Roy(John Radcliffe Hospital), Elena Sučilienė(Vilnius University), Lola Falcón-Neyra(Hospital Universitario Virgen del Rocío), Olga Bilogortseva(National Academy of Medical Sciences of Ukraine), Péter Hoffmann(Kliniken Essen-Mitte), Vira Chechenyeva(National Academy of Medical Sciences of Ukraine), Joan Calzada‐Hernández(Hospital Sant Joan de Déu Barcelona), Elisabeth H. Schölvinck(University Medical Center Groningen), Folke Brinkmann(University Hospitals of the Ruhr-University of Bochum)
Cited by 38
Related Papers
Clinical Features, Treatment, and Outcome of Macrophage Activation Syndrome Complicating Systemic Juvenile Idiopathic Arthritis: A Multinational, Multicenter Study of 362 Patients
|Arthritis & Rheumatology|2014|430
Cross-specificity of protective human antibodies against Klebsiella pneumoniae LPS O-antigen
|Nature Immunology|2018|155
Impfen bei Immundefizienz
|Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz|2019|147
The Extended Clinical Phenotype of 26 Patients with Chronic Mucocutaneous Candidiasis due to Gain-of-Function Mutations in STAT1
|Journal of Clinical Immunology|2015|137
Functional rare and low frequency variants in BLK and BANK1 contribute to human lupus
|Nature Communications|2019|122